Nanjing Pharmaceutical Group Company Limited (SHA:600713)

China flag China · Delayed Price · Currency is CNY
4.980
+0.010 (0.20%)
Jun 18, 2026, 3:00 PM CST
Market Cap6.51B -4.3%
Revenue (ttm)54.56B +1.1%
Net Income622.04M +5.6%
EPS0.41 -8.0%
Shares Out 1.31B
PE Ratio12.00
Forward PEn/a
Dividend0.17 (3.38%)
Ex-Dividend DateJun 30, 2025
Volume7,188,400
Open4.970
Previous Close4.970
Day's Range4.930 - 5.020
52-Week Range4.810 - 6.650
Beta0.24
AnalystsStrong Buy
Price Target11.60 (+132.93%)
Earnings DateAug 28, 2026

About SHA:600713

Nanjing Pharmaceutical Group Company Limited engages in the distribution of pharmaceuticals, medical devices, and health products in China. It also involved in the wholesale and retail of pharmaceuticals; provision of internet + Chinese medicine pharmacy service platform; and pharmaceutical third-party logistics services. The company was formerly known as NanJing Pharmaceutical Company Limited and change its name to Nanjing Pharmaceutical Group Company Limited in December 2025. Nanjing Pharmaceutical Group Company Limited was founded in 1951 an... [Read more]

Sector Healthcare
Founded 1951
Employees 4,697
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600713
Full Company Profile

Financial Performance

In 2025, SHA:600713's revenue was 54.96 billion, an increase of 2.36% compared to the previous year's 53.70 billion. Earnings were 624.83 million, an increase of 9.50%.

Financial Statements